Sijia Wang

Henan University of Technology

Health Outcomes Studied

• Improved Gut Microbiota Composition

Papers (2)

• 2026
  Clinical Safety and Tolerability of <i>Bifidobacterium bifidum</i> BBi32: An 8-Week Randomized, Double-Blind, Placebo-Controlled Trial With Genomic and In Vitro Corroboration.10.1002/fsn3.71420
• 2026
  Gut microbiota and immune regulation by Lactobacillus delbrueckii subsp. bulgaricus LB42: From preclinical safety assessment to clinical evidence.10.1016/j.fct.2025.115851